Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2010

01-07-2010 | Review

Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany

Authors: M. van der Linden, R. R. Reinert

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2010

Login to get access

Abstract

This retrospective analysis examined the pneumococcal serotype distribution of acute otitis media in Germany from 1995 to 2007. Data from the German National Reference Centre for Streptococci included 512 cases of pneumococcal otitis media in children and adults. Infections were mainly seen in children aged <5 years, who represented 67.0% of all reported cases. Most isolates (86.7%) were from spontaneous ruptures of the tympanum; 11.1% of the isolates were from otogenic sepsis or meningitis. Serotype 19F was the leading serotype (21.5%); serotype 3 (13.9%) was also often encountered. In children aged <5 years, the 7-valent, 10-valent, and 13-valent pneumococcal conjugate vaccines covered 54.3%, 60.2%, and 84.6% of the serotypes, respectively. Reduced penicillin susceptibility (minimum inhibitory concentration ≥0.1 mg/l) was seen in 11.0% of strains; 22.4% of strains were resistant to macrolides. Although based on a very limited selection of acute otitis media isolates, this analysis provides an estimate of the pneumococcal serotypes responsible for otitis media in Germany and underscores the need for future prospective studies.
Literature
1.
go back to reference Fletcher MA, Fritzell B (2007) Brief review of the clinical effectiveness of PREVENAR® against otitis media. Vaccine 25:2507–2512CrossRefPubMed Fletcher MA, Fritzell B (2007) Brief review of the clinical effectiveness of PREVENAR® against otitis media. Vaccine 25:2507–2512CrossRefPubMed
2.
go back to reference Palmu AAI, Herva E, Savolainen H, Karma P, Makela PH, Kilpi TM (2004) Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 38:234–242CrossRefPubMed Palmu AAI, Herva E, Savolainen H, Karma P, Makela PH, Kilpi TM (2004) Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 38:234–242CrossRefPubMed
3.
go back to reference Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E (2002) Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J 21:859–865CrossRefPubMed Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E (2002) Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J 21:859–865CrossRefPubMed
4.
go back to reference Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR (1995) Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978–1994: implications for development of a conjugate vaccine. J Infect Dis 171:885–889PubMed Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR (1995) Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978–1994: implications for development of a conjugate vaccine. J Infect Dis 171:885–889PubMed
5.
go back to reference Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19:187–195CrossRefPubMed Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19:187–195CrossRefPubMed
6.
go back to reference Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344:403–409CrossRefPubMed Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344:403–409CrossRefPubMed
7.
go back to reference Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P (2003) Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22:10–16CrossRefPubMed Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P (2003) Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22:10–16CrossRefPubMed
8.
go back to reference Palmu AAI, Verho J, Jokinen J, Karma P, Kilpi TM (2004) The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J 23:732–738CrossRefPubMed Palmu AAI, Verho J, Jokinen J, Karma P, Kilpi TM (2004) The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J 23:732–738CrossRefPubMed
9.
go back to reference Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R (2009) Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 28:277–282CrossRefPubMed Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R (2009) Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 28:277–282CrossRefPubMed
10.
go back to reference Rodgers GL, Arguedas A, Cohen R, Dagan R (2009) Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 27:3802–3810CrossRefPubMed Rodgers GL, Arguedas A, Cohen R, Dagan R (2009) Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 27:3802–3810CrossRefPubMed
11.
go back to reference Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E (2004) Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23:829–833CrossRefPubMed Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E (2004) Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23:829–833CrossRefPubMed
12.
go back to reference Casey JR, Pichichero ME (2004) Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J 23:824–828CrossRefPubMed Casey JR, Pichichero ME (2004) Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J 23:824–828CrossRefPubMed
13.
go back to reference McEllistrem MC, Adams J, Mason EO, Wald ER (2003) Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis 188:1679–1684CrossRefPubMed McEllistrem MC, Adams J, Mason EO, Wald ER (2003) Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis 188:1679–1684CrossRefPubMed
14.
go back to reference Zhou F, Shefer A, Kong Y, Nuorti JP (2008) Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004. Pediatrics 121:253–260CrossRefPubMed Zhou F, Shefer A, Kong Y, Nuorti JP (2008) Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004. Pediatrics 121:253–260CrossRefPubMed
16.
go back to reference Ziebold C, von Kries R, Siedler A, Schmitt HJ (2000) Epidemiology of pneumococcal disease in children in Germany. Acta Paediatr Suppl 435:17–21CrossRef Ziebold C, von Kries R, Siedler A, Schmitt HJ (2000) Epidemiology of pneumococcal disease in children in Germany. Acta Paediatr Suppl 435:17–21CrossRef
17.
go back to reference Reinert RR, Simic S, Al-Lahham A, Reinert S, Lemperle M, Lütticken R (2001) Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study. J Clin Microbiol 39:1187–1189CrossRefPubMed Reinert RR, Simic S, Al-Lahham A, Reinert S, Lemperle M, Lütticken R (2001) Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study. J Clin Microbiol 39:1187–1189CrossRefPubMed
18.
go back to reference Reinert RR, van der Linden M, Seegmuller I, Al-Lahham A, Siedler A, Weissmann B, Toschke AM, von Kries R (2007) Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany. Clin Microbiol Infect 13:363–368CrossRefPubMed Reinert RR, van der Linden M, Seegmuller I, Al-Lahham A, Siedler A, Weissmann B, Toschke AM, von Kries R (2007) Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany. Clin Microbiol Infect 13:363–368CrossRefPubMed
19.
go back to reference Siedler A, Reinert RR, Toschke M, Al-Lahham A, von Kries R (2005) Regional differences in the epidemiology of invasive pneumococcal disease in toddlers in Germany. Pediatr Infect Dis J 24:1114–1115CrossRefPubMed Siedler A, Reinert RR, Toschke M, Al-Lahham A, von Kries R (2005) Regional differences in the epidemiology of invasive pneumococcal disease in toddlers in Germany. Pediatr Infect Dis J 24:1114–1115CrossRefPubMed
20.
go back to reference von Kries R, Hermann M, Al-Lahham A, Siedler A, Reinert RR (2002) Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial? Eur J Pediatr 161:S140–S143CrossRef von Kries R, Hermann M, Al-Lahham A, Siedler A, Reinert RR (2002) Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial? Eur J Pediatr 161:S140–S143CrossRef
21.
go back to reference von Kries R, Hermann M, Hachmeister A, Siedler A, Schmitt HJ, Al-Lahham A, Reinert RR (2002) Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatr Infect Dis J 21:1017–1023CrossRef von Kries R, Hermann M, Hachmeister A, Siedler A, Schmitt HJ, Al-Lahham A, Reinert RR (2002) Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatr Infect Dis J 21:1017–1023CrossRef
22.
go back to reference von Kries R, Siedler A, Schmitt HJ, Reinert RR (2000) Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31:482–487CrossRef von Kries R, Siedler A, Schmitt HJ, Reinert RR (2000) Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31:482–487CrossRef
23.
go back to reference Reinert RR, Haupts S, van der Linden M, Heeg C, Cil MY, Al-Lahham A, Fedson DS (2005) Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003. Clin Microbiol Infect 11:985–991CrossRefPubMed Reinert RR, Haupts S, van der Linden M, Heeg C, Cil MY, Al-Lahham A, Fedson DS (2005) Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003. Clin Microbiol Infect 11:985–991CrossRefPubMed
24.
go back to reference Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial disk susceptibility tests; approved standard—9th edition. CLSI, Wayne, PA, USA Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial disk susceptibility tests; approved standard—9th edition. CLSI, Wayne, PA, USA
25.
go back to reference Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist A-C, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A (2006) Effectiveness of seven-valent pneumoccoccal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368:1495–1502CrossRefPubMed Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist A-C, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A (2006) Effectiveness of seven-valent pneumoccoccal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368:1495–1502CrossRefPubMed
26.
go back to reference Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsene J-P, Lommel P, Dieussaert I, Schuerman L (2009) Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 28:S66–S76CrossRefPubMed Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsene J-P, Lommel P, Dieussaert I, Schuerman L (2009) Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 28:S66–S76CrossRefPubMed
27.
go back to reference Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L (2006) Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367:740–748CrossRefPubMed Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L (2006) Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367:740–748CrossRefPubMed
28.
go back to reference Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, Jacobs MR, Kaplan SL, Levy C, Lopez EL, Mason EO Jr, Syriopoulou V, Wynne B, Bryant J (2002) Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 21:1008–1016CrossRefPubMed Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, Jacobs MR, Kaplan SL, Levy C, Lopez EL, Mason EO Jr, Syriopoulou V, Wynne B, Bryant J (2002) Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 21:1008–1016CrossRefPubMed
29.
go back to reference Vergison A, Reinert RR (2007) Streptococcus pneumoniae incidence in Western Europe. Lancet Infect Dis 7:240–242CrossRefPubMed Vergison A, Reinert RR (2007) Streptococcus pneumoniae incidence in Western Europe. Lancet Infect Dis 7:240–242CrossRefPubMed
Metadata
Title
Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany
Authors
M. van der Linden
R. R. Reinert
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0945-8

Other articles of this Issue 7/2010

European Journal of Clinical Microbiology & Infectious Diseases 7/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.